We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is BXP Stock Worth Retaining in Your Portfolio for the Long Run?
Read MoreHide Full Article
Key Takeaways
BXP benefits from strong leasing, improving occupancy and a diversified tenant base across gateway markets.
BXP's asset sales, development pipeline and liquidity support long-term growth.
Office leasing competition, project execution and a lower dividend remain key risks.
BXP (BXP - Free Report) is a leading office REIT that owns, develops and manages premium workplaces across six major U.S. gateway markets. Its portfolio includes office, retail, residential and hotel properties, with office assets generating most of its revenues. The company is known for high-quality buildings and long-term tenant relationships. Recent leasing activity has supported occupancy, while property sales have strengthened liquidity and helped fund redevelopment and new projects. A strong balance sheet helps finance future growth plans.
However, office demand remains competitive, resulting in higher leasing incentives and slower occupancy gains. Large development projects carry execution and funding risks, while the lower dividend makes the stock less appealing for income-focused investors.
In the past three months, shares of this Zacks Rank #3 (Hold) company have gained 34.1% compared with the industry's growth of 5.4%.
Image Source: Zacks Investment Research
What Aids BXP?
BXP continues to benefit from steady demand for premium office space in major gateway markets. During the first quarter of 2026, the company completed 68 lease transactions covering more than 1.1 million square feet, with a weighted-average lease term of 8.7 years. Overall portfolio occupancy improved 70 basis points from the previous quarter to 87.4%, and the leased rate increased 150 basis points to 90.9%. Around 1.6 million square feet of signed leases have yet to begin, with nearly 90% expected to commence by the end of 2026.
The company also benefits from a diversified tenant base that provides stable rental income. As of March 31, 2026, the top 20 tenants accounted for 29.09% of BXP's share of annualized rental obligations, while their weighted-average remaining lease term was 8.9 years. This balanced tenant mix helps reduce dependence on any single customer and supports predictable cash flows.
BXP’s disciplined capital allocation strategy further strengthens its position. Since the September 2025 investor conference, aggregate net proceeds have totaled about $1.2 billion, and management continues to target approximately $1.9 billion by 2028 through additional asset sales. With several additional assets under contract and more being marketed, ongoing dispositions can help fund strategic priorities while easing leverage over time.
Growth is also supported by an active development pipeline and a strong balance sheet. BXP has six office, life science and residential projects under development totaling 3.4 million square feet, representing about $3.6 billion of investment, with 61% pre-leased as of April 24, 2026. These projects are expected to add nearly $300 million to BXP's share of cash NOI after stabilization. At the same time, the company ended the first quarter with $2.1 billion of liquidity, including about $0.6 billion in cash and $1.5 billion of available revolving credit capacity. BXP’s share of net debt to EBITDAre (annualized) was 8.50X, and fixed charge coverage was 2.40X as of March 31, 2026.
What’s Hurting BXP?
BXP continues to face intense competition from other office landlords, making it harder to increase rents and retain tenants without offering concessions. At the end of the first quarter of 2026, the portfolio was 90.9% leased but only 87.4% occupied, indicating that a sizeable portion of signed leases had not yet started.
The company's development pipeline also brings execution risk. It has six projects totaling 3.4 million square feet, representing about $3.6 billion of investment. The flagship 343 Madison Avenue project is scheduled for completion in 2029, and any delays in leasing, financing or recapitalization could postpone stabilization and put pressure on FFO.
BXP's dividend is less attractive after the 2025 reduction. The quarterly dividend was cut to 70 cents per share, down 27.4% from the previous level. As of March 31, 2026, the annualized dividend stood at $2.80 per share, offering a 5.4% yield. While the lower payout supports the balance sheet, it may reduce the stock's appeal for income-focused investors.
The Zacks Consensus Estimate for AHR’s 2026 FFO per share has moved up marginally to $2.07 over the past month.
The consensus estimate for APLE’s 2026 FFO per share has moved up marginally to $1.58 per share over the past month.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.
View the Zacks #1 Rank List
Image: Bigstock
Is BXP Stock Worth Retaining in Your Portfolio for the Long Run?
Key Takeaways
BXP (BXP - Free Report) is a leading office REIT that owns, develops and manages premium workplaces across six major U.S. gateway markets. Its portfolio includes office, retail, residential and hotel properties, with office assets generating most of its revenues. The company is known for high-quality buildings and long-term tenant relationships. Recent leasing activity has supported occupancy, while property sales have strengthened liquidity and helped fund redevelopment and new projects. A strong balance sheet helps finance future growth plans.
However, office demand remains competitive, resulting in higher leasing incentives and slower occupancy gains. Large development projects carry execution and funding risks, while the lower dividend makes the stock less appealing for income-focused investors.
In the past three months, shares of this Zacks Rank #3 (Hold) company have gained 34.1% compared with the industry's growth of 5.4%.
Image Source: Zacks Investment Research
What Aids BXP?
BXP continues to benefit from steady demand for premium office space in major gateway markets. During the first quarter of 2026, the company completed 68 lease transactions covering more than 1.1 million square feet, with a weighted-average lease term of 8.7 years. Overall portfolio occupancy improved 70 basis points from the previous quarter to 87.4%, and the leased rate increased 150 basis points to 90.9%. Around 1.6 million square feet of signed leases have yet to begin, with nearly 90% expected to commence by the end of 2026.
The company also benefits from a diversified tenant base that provides stable rental income. As of March 31, 2026, the top 20 tenants accounted for 29.09% of BXP's share of annualized rental obligations, while their weighted-average remaining lease term was 8.9 years. This balanced tenant mix helps reduce dependence on any single customer and supports predictable cash flows.
BXP’s disciplined capital allocation strategy further strengthens its position. Since the September 2025 investor conference, aggregate net proceeds have totaled about $1.2 billion, and management continues to target approximately $1.9 billion by 2028 through additional asset sales. With several additional assets under contract and more being marketed, ongoing dispositions can help fund strategic priorities while easing leverage over time.
Growth is also supported by an active development pipeline and a strong balance sheet. BXP has six office, life science and residential projects under development totaling 3.4 million square feet, representing about $3.6 billion of investment, with 61% pre-leased as of April 24, 2026. These projects are expected to add nearly $300 million to BXP's share of cash NOI after stabilization. At the same time, the company ended the first quarter with $2.1 billion of liquidity, including about $0.6 billion in cash and $1.5 billion of available revolving credit capacity. BXP’s share of net debt to EBITDAre (annualized) was 8.50X, and fixed charge coverage was 2.40X as of March 31, 2026.
What’s Hurting BXP?
BXP continues to face intense competition from other office landlords, making it harder to increase rents and retain tenants without offering concessions. At the end of the first quarter of 2026, the portfolio was 90.9% leased but only 87.4% occupied, indicating that a sizeable portion of signed leases had not yet started.
The company's development pipeline also brings execution risk. It has six projects totaling 3.4 million square feet, representing about $3.6 billion of investment. The flagship 343 Madison Avenue project is scheduled for completion in 2029, and any delays in leasing, financing or recapitalization could postpone stabilization and put pressure on FFO.
BXP's dividend is less attractive after the 2025 reduction. The quarterly dividend was cut to 70 cents per share, down 27.4% from the previous level. As of March 31, 2026, the annualized dividend stood at $2.80 per share, offering a 5.4% yield. While the lower payout supports the balance sheet, it may reduce the stock's appeal for income-focused investors.
Stock to Consider
Some better-ranked stocks from the other REIT sector are American Healthcare REIT (AHR - Free Report) and Apple Hospitality REIT (APLE - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for AHR’s 2026 FFO per share has moved up marginally to $2.07 over the past month.
The consensus estimate for APLE’s 2026 FFO per share has moved up marginally to $1.58 per share over the past month.
Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.